Tsai, D.H.-T.; Harmon, E.; Goelen, J.; Barry, H.E.; Chen, L.-Y.; Hsia, Y.
Evaluating the Risk–Benefit Profile of Corticosteroid Therapy for COVID-19 Patients: A Scoping Review. Pharmacy 2024, 12, 129.
https://doi.org/10.3390/pharmacy12040129
AMA Style
Tsai DH-T, Harmon E, Goelen J, Barry HE, Chen L-Y, Hsia Y.
Evaluating the Risk–Benefit Profile of Corticosteroid Therapy for COVID-19 Patients: A Scoping Review. Pharmacy. 2024; 12(4):129.
https://doi.org/10.3390/pharmacy12040129
Chicago/Turabian Style
Tsai, Daniel Hsiang-Te, Emma Harmon, Jan Goelen, Heather E. Barry, Li-Yang Chen, and Yingfen Hsia.
2024. "Evaluating the Risk–Benefit Profile of Corticosteroid Therapy for COVID-19 Patients: A Scoping Review" Pharmacy 12, no. 4: 129.
https://doi.org/10.3390/pharmacy12040129
APA Style
Tsai, D. H. -T., Harmon, E., Goelen, J., Barry, H. E., Chen, L. -Y., & Hsia, Y.
(2024). Evaluating the Risk–Benefit Profile of Corticosteroid Therapy for COVID-19 Patients: A Scoping Review. Pharmacy, 12(4), 129.
https://doi.org/10.3390/pharmacy12040129